Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2025-12-26 @ 3:13 AM
Study NCT ID:
NCT06786520
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-06-19
First Post:
2025-01-15
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Cabotegravir Ultra Long-acting (CAB ULA) Following Switch From Cabotegravir Long-acting (CAB LA) in Healthy Adults
Sponsor:
ViiV Healthcare
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-01-17
Start Date Type:
ACTUAL
Primary Completion Date:
2027-03-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-11-08
Completion Date Type:
ESTIMATED
First Submit Date:
2025-01-15
First Submit QC Date:
None
Study First Post Date:
2025-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-16
Last Update Post Date:
2025-06-19
Last Update Post Date Type:
ACTUAL